WONGWIKROM W. A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY. ASEAN J Radiol [Internet]. 2023 Apr. 26 [cited 2024 May 2];14(1):1-4. Available from: https://asean-journal-radiology.org/index.php/ajr/article/view/809